Zevra Therapeutics's total assets for Q3 2024 were $191.55M, an increase of 32.65% from the previous quarter. ZVRA total liabilities were $121.78M for the fiscal quarter, a 8.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.